Abstract
This paper assesses and describes the estimated coverage of the Measles Rubella (MR) campaign in each district; the national estimate of coverage for Human Papilloma Virus (HPV) vaccination campaign and Vitamin A supplementation simultaneously implemented in 2013. We applied descriptive statistics and epidemiological tools to the outcomes of the campaigns to assess the coverage achieved on the different child and maternal health interventions. We also assessed the Adverse Events following Immunization (AEFI) where the evaluation was used at the same time to assess the routine immunization performance coverage for children 12-24 months for all childhood antigens, Tetanus Toxoid coverage among mothers of infants, combined with routine immunization performance evaluation, skilled delivery and bed nets use in Rwanda. Results indicated that among the eligible targets, 97.5% received MR vaccine, 91% received HPV doses, and 83% got Vitamin A. The integrated vaccination of MR with HPV did not result in any serious AEFI. Coverage for antigens and doses given early in life was above 95% with card retention of 80%. BCG to measles dropout by card was 8.5%. Main reasons for non-vaccination indicated need for more specific immunization education. About 96.8% of mothers delivered in health institutions and 95% of the mothers slept under bed nets the night before the survey. Rwanda successfully implemented an integrated coverage evaluation survey of the integrated vaccination campaign and routine immunization with statistically valid estimates. We drew lessons that information on routine immunization can be collected during post campaign survey evaluations. The district estimates should guide the programme performance improvement.
Highlights
Immunization programmes in the African Region have recorded remarkable successes in the last four decades, contributing to the eradication of smallpox, elimination of polio, control of measles and reduction by 99% of the incidence of other vaccine-preventable diseases[1]
We assessed the Adverse Events following Immunization (AEFI) where the evaluation was used at the same time to assess the routine immunization performance coverage for children [12-24] months for all childhood antigens, Tetanus Toxoid coverage among mothers of infants, combined with routine immunization performance evaluation, skilled delivery and bed nets use in Rwanda
The integrated vaccination of Measles Rubella (MR) with Human Papilloma Virus (HPV) did not result in any serious AEFI
Summary
Immunization programmes in the African Region have recorded remarkable successes in the last four decades, contributing to the eradication of smallpox, elimination of polio, control of measles and reduction by 99% of the incidence of other vaccine-preventable diseases[1]. Between 1978 and April 2013 a total of 12 antigens had been introduced into the nation’s immunization system. These include antigens such as Bacillus Calmettie Guuérin, Diphtheria, Pertussis, Tetanus, Oral Polio Vaccine, Measles, Hepatitis B, Haemophilus influenza type b, Pneumococcal Vaccine, Human Papilloma Virus, Rotavirus and Measles-Rubella antigens to prevent and control vaccine-preventable diseases. There has been a consistent reduction in infant and child mortality in the country
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have